Modern Immunotherapy for Appropriate Cancer Patients
Immunotherapy is an important area of modern cancer treatment that uses medicines to help the immune system recognize and respond to cancer cells. Immune checkpoint inhibitors are among the immunotherapy approaches used in oncology.
Dr. Adhip Arora has documented research focus on immunotherapy and checkpoint inhibitors and has been involved in clinical research evaluating pembrolizumab in triple-negative breast cancer. His PLANeT Trial research investigated low-dose pembrolizumab combined with neoadjuvant chemotherapy in localized triple-negative breast cancer.
Immunotherapy continues to evolve rapidly. Dr. Arora's involvement in clinical research involving pembrolizumab and triple-negative breast cancer reflects his academic engagement with emerging cancer treatment approaches.
Treatment decisions are made according to the patient's individual diagnosis and clinical circumstances.
